Hui Kong

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Pulmonary Arterial Hypertension

Top Venues

Oxidative medicine and cellular longevity

Cancer cell international

This page only lists publications with an associated author ORCID identifier.

Publications

Min Yu, Xuecheng Wu, Liyao Peng, Mingxia Yang, Hong Zhou, Jian Xu, Jingjing Wang, Hong Wang, Wei-Ping Xie, Hui Kong
Inhibition of Bruton's Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization. Oxidative medicine and cellular longevity 2022 (2022)
Ling-Yun Ye, Li-Xiang Sun, Xiu-Hua Zhong, Xue-Song Chen, Song Hu, Rong-Rong Xu, Xiao-Ning Zeng, Wei-Ping Xie, Hui Kong
The structure of blood-tumor barrier and distribution of chemotherapeutic drugs in non-small cell lung cancer brain metastases. Cancer cell international 21 (1) (2021)
Mengyu He, Wen Shi, Min Yu, Xiang Li, Jian Xu, Jiali Zhu, Linling Jin, Wei-Ping Xie, Hui Kong
Nicorandil Attenuates LPS-Induced Acute Lung Injury by Pulmonary Endothelial Cell Protection via NF-κB and MAPK Pathways. Oxidative medicine and cellular longevity 2019 (2019)